Serotonin Syndrome Associated with Antidepressant Discontinuation in a Neonate Following Drug Exposure During Pregnancy
Abstract
Sudden withdrawal of some drugs leads to withdrawal issues. We describe a baby girl who was indirectly exposed to venlafaxine as her mother was administered this drug during pregnancy for treatment of depression. The subject presented with involuntary movement of the limbs. The mother had also encountered similar scenario along with some other symptoms after she suddenly discontinued her medication. The symptoms of the mother completely resolved a few hours after the she took another dose of venlafaxine. The baby was kept under observation and recovered completely without any intervention. We suggest that healthcare professionals should be aware that patients may require tapering of anti-depressants before discontinuation.
Downloads
References
Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry. 1997 Jul;58(7):291-7. https://doi.org/10.4088/jcp.v58n0702
Farah A, Lauer TE. Possible venlafaxine withdrawal syndrome. Am J Psychiatry. 1996;153(4):576. https://doi.org/10.1176/ajp.153.4.576a
Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997;154(12):1760-2. https://doi.org/10.1176/ajp.154.12.1760
Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005 May 18;293(19):2372-83. https://doi.org/10.1001/jama.293.19.2372
Copyright (c) 2021 Dolma Gurung et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
